Answers are grounded in this paper and cite their sources.
DOACs are a newer class of anticoagulants with potential advantages over warfarin, requiring careful patient-provider discussion regarding perioperative management and bleeding risks.
DOACs are a new group of blood-thinner medications that may have some advantages over warfarin. A health care provider will look at several different factors to help patients decide if a DOAC is a good choice. Patients taking DOACs should discuss medication changes, a plan for taking the DOAC before and after a surgery, and any bleeding side effects with their health care provider.
No takes yet. Share an insight, caveat, or question.
Vazquez et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: